Biostage Inc. (BSTG) Stock Price & Overview

NASDAQ:BSTG

0.23

-0.07 (-23.33%)

At close: Oct 5, 2017

0.25

+0.02 (+8.7%)

After Hours: 10/5/2017, 8:10:00 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of BSTG is 0.23 null. Today BSTG is down by -23.33%. In the past month the price decreased by -25.32%. In the past year, price decreased by -75.53%.

BSTG Key Statistics

52-Week Range0.2 - 1.42

1-Month Range0.2 - 0.36

Market Cap: 8.977M
P/E: N/A
Fwd P/E: N/A
EPS (TTM): -0.61
Dividend Yield: N/A

BSTG Stock Performance

Today

-23.33%

1 Week

-25.81%

1 Month

-25.32%

3 Months

-46.51%

Longer-term

6 Months -28.13%

1 Year -75.53%

2 Years N/A

3 Years N/A

5 Years N/A

10 Years N/A

BSTG Stock Chart

BSTG Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to BSTG. When comparing the yearly performance of all stocks, BSTG is a bad performer in the overall market: 96.23% of all stocks are doing better.

Chartmill TA Rating

Chartmill Setup Rating

BSTG Full Technical Analysis Report

BSTG Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BSTG. BSTG may be in some trouble as it scores bad on both profitability and health.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

BSTG Full Fundamental Analysis Report

BSTG Earnings

Next Earnings DateApr 11, 2022

Last Earnings DateN/A

BSTG Earnings History

BSTG Forecast & Estimates

Analysts

AnalystsN/A

Price TargetN/A

EPS Next YN/A

Revenue Next YearN/A

BSTG Forecast & Estimates

BSTG Financial Highlights

Over the last trailing twelve months BSTG reported a non-GAAP Earnings per Share(EPS) of -0.614. The EPS increased by 7.92% compared to the year before.

Income Statements

Revenue(TTM)54.00K

Net Income(TTM)-13.84M

		Industry Rank	Sector Rank
PM (TTM)	-25627.78%
ROA	-297.23%
ROE	-1081.17%
Debt/Equity	0

Chartmill High Growth Momentum

EPS Q2Q%44.39%

Sales Q2Q%-100%

EPS 1Y (TTM)7.92%

Revenue 1Y (TTM)-26.03%

BSTG financials

BSTG Ownership

Ownership

Inst Owners0.03%

Shares39.03M

Float37.47M

Ins Owners6.21%

Short Float %N/A

Short RatioN/A

BSTG Ownership

About BSTG

Company Profile

Biostage, Inc. is a biotechnology company. It is engaged in developing bioengineered organ implants based on the company's new Cellframe (TM) technology to treat life-threatening conditions of the esophagus, trachea or bronchus. Biostage Inc., formerly known as Harvard Apparatus Regenerative Technology Inc., is based in HOLLISTON, Mass.

Company Info

Biostage Inc.

84 October Hill Road Suite 11

Holliston MA 01746

CEO: James McGorry

Phone: 774-233-7300

Biostage Inc. / BSTG FAQ

What does BSTG do?

What is the current price of BSTG stock?

The current stock price of BSTG is 0.23 null. The price decreased by -23.33% in the last trading session.

What is the dividend status of Biostage Inc.?

BSTG does not pay a dividend.

How is the ChartMill rating for Biostage Inc.?

BSTG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.

Where is Biostage Inc. (BSTG) stock traded?

BSTG stock is listed on the Nasdaq exchange.

How is the valuation of Biostage Inc. (BSTG) based on its PE ratio?

Biostage Inc. (BSTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).

Would investing in Biostage Inc. be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BSTG.